OT I Mouse Details
From the Walter and Eliza Hall Institute, Victoria, Australia, to Charles River France in 2002. These homozygous mice contain transgenic inserts for mouse Tcra-V2 and Tcrb-V5 genes. The transgenic T cell receptor was designed to recognize ovalbumin residues 257-264 in the context of H2Kb and used to study the role of peptides in positive selection and the response of CD8+ T cells to antigen. Like most TCR transgenics, these mice are somewhat immunodeficient.
Try out the OT I mouse with our animal model evaluation program
Not available
UNIT:A04E
Download the Report
➤ DOWNLOAD OUR CATALOG for instant access to Standard List Pricing
➤ TALK TO US to discuss organization or volume-based discounts
Already have an eCommerce portal account?* Login to order research models, obtain quotes, view organization-specific pricing, and see inventory. Processing time required to validate new eCommerce access requests.
*eCommerce is available in US, Canada, UK, France, Germany, Austria, Netherlands, Denmark, Finland, Norway, Sweden, Spain, Portugal, Belgium, Luxembourg, and Switzerland
Technical Resource
- Didierlaurent AM, Collignon C, Bourguignon P, Wouters S, Fierens K, Fochesato M, Dendouga N, Langlet C, Malissen B, Lambrecht BN, Garçon N, Van Mechelen M, Morel S. Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells. Journal of Immunology: epub ahead of print 2014 July 14
Optimize Your Autoimmune and Inflammatory Disease Program
Advance your drug discovery with translational immunology assays and inflammation models that reflect the human immune system. Combine these with full bioanalytical support for decision-driving data that moves your therapy to the clinic faster.
Learn More
